All Access Pass - 1 FREE Month!
Institutional email required, no credit card necessary.
Serum Sickness
FREE ONE-MONTH ACCESS
Institutional (.edu or .org) Email Required
Register Now!
No institutional email? Start your 1-week free trial, now!
- or -
Log in through OpenAthens

Serum Sickness

Systemic Serum Sickness
  • Manifests throughout the body.
  • Serum sickness can be induced by older vaccines that used antibodies from other species, such as horses and rabbits; though rare, it can also occur after transfusions. Anti-venom reactions can occur when, for example, anti-snake venom treatment is administered to a previously sensitized individual. Newer anti-venom treatments avoid this reaction.
  • Graphically:
— X-axis = "Time in Days"; Y-axis = "Plasma levels" — At time 0, show that plasma levels of foreign proteins spike immediately after administration, then slowly decline for a period; Initially, plasma antibody concentration is low. — Then, show that as production of plasma antibodies increases, immune complexes are formed; thus, the concentration of foreign protein is rapidly reduced. — Furthermore, show that the appearance of serum sickness symptoms coincides with immune complex formation, and typically resolve on their own.
  • Common manifestations of serum sickness include: blotchy skin rashes, joint pain, peripheral edema, and fever.
Serum Sickness is an example of a Hypersensitivity Type II reaction:
Pathogenesis of immune complex-mediated hypersensitivity:
  • Immune complexes become deposited on the vessel wall (or, in some cases, in the tissues).
  • As a result, complement and neutrophil activation occurs, leading to the release of pro-inflammatory cytokines, enzymes, and reactive oxygen species.
  • Increased vessel permeability allows the inflammatory molecules to cause additional tissue damage outside of the vessel.